40 results on '"Turtle, Cameron J."'
Search Results
2. Figure S2 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
3. Data from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
4. Figure S3 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
5. Figure S2 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
6. Figure S7 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
7. Figure S4 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
8. Figure S1 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
9. Supplementary text_tables_figurelegends from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
10. Data from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
11. Figure S5 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
12. Figure S3 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
13. Figure S7 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
14. Figure S2 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
15. Data from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
16. Figure S2 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
17. Figure S4 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
18. Figure S6 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
19. Table S2 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
20. Table S1 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
21. Table S3 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
22. Figure S3 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
23. Figure S3 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
24. Data from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
25. Supplementary text_tables_figurelegends from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
26. Table S3 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
27. Table S2 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
28. Figure S4 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
29. Figure S1 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
30. Figure S5 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
31. Figure S1 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
32. Figure S5 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
33. Figure S1 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
34. Figure S4 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
35. Table S1 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
36. Figure S5 from Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
37. Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia
38. Abstract CT131: A phase I study of adoptive immunotherapy for advanced ROR1+ malignancies with defined subsets of autologous T cells expressing a ROR1-specific chimeric antigen receptor (ROR1-CAR)
39. Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
40. Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.